Page last updated: 2024-09-05

sb 203580 and lipoxin a4

sb 203580 has been researched along with lipoxin a4 in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(lipoxin a4)
Trials
(lipoxin a4)
Recent Studies (post-2010) (lipoxin a4)
3,48941,13783317398

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)lipoxin a4 (IC50)
Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)0.0001
N-formyl peptide receptor 2Homo sapiens (human)0.0119
Nuclear factor NF-kappa-B p100 subunit Homo sapiens (human)0.0001
Transcription factor p65Homo sapiens (human)0.0001

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bai, C; Chai, L; Deng, P; Jia, Y; Li, J; Liu, C; Sun, Q; Zhao, X; Zheng, C1

Other Studies

1 other study(ies) available for sb 203580 and lipoxin a4

ArticleYear
Lipoxin A4-Mediated p38 MAPK Signaling Pathway Protects Mice Against Collagen-Induced Arthritis.
    Biochemical genetics, 2021, Volume: 59, Issue:1

    Topics: Animals; Anisomycin; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Proliferation; Collagen; Female; Imidazoles; Inflammation; Lipoxins; MAP Kinase Signaling System; Mice; Mice, Inbred DBA; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Synovial Membrane

2021